Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells
Authors:
- Yuan-Jian LiYLYuan-Jian Li
- 1 May 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 356 (4) , 880-885
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Elevated Homocysteine Is Associated With Reduced Regional Left Ventricular FunctionCirculation, 2007
- Suppression of Endothelial Progenitor Cells in Human Coronary Artery Disease by the Endogenous Nitric Oxide Synthase Inhibitor Asymmetric DimethylarginineJACC, 2005
- Plasma homocysteine predicts progression of atherosclerosisAtherosclerosis, 2005
- Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor?International Journal of Cardiology, 2005
- Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Homocysteine induces oxidative stress by uncoupling of no synthase activity through reduction of tetrahydrobiopterinFree Radical Biology and Medicine, 2004
- Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic casesThrombosis Research, 2002
- Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic AcidThrombosis Research, 2001
- Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic HumansArteriosclerosis, Thrombosis, and Vascular Biology, 2000